Prevention and treatment of cryptosporidiosis in immunocompromised patients (Q24246356)

2

0 references

Chitra Arumugam

3

0 references

Paul R. Hunter

4

0 references

Nuhu Usman

Cochrane Database of Systematic Reviews

5

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Prospective trial of paromomycin for cryptosporidiosis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

A randomized, blinded, controlled trial investigating the gastrointestinal health effects of drinking water quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Combination drug therapy for cryptosporidiosis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Antibody-based immunotherapy of cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Cryptosporidiosis: sources of infection and guidelines for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Cryptosporidiosis and the challenges of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Gene transfer in the evolution of parasite nucleotide biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Cryptosporidiosis in children during a massive waterborne outbreak in Milwaukee, Wisconsin: clinical, laboratory and epidemiologic findings

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Spiramycin is not effective in treating cryptosporidium diarrhea in infants: results of a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Roxithromycin treatment for diarrhoea caused by Cryptosporidium spp. in patients with AIDS

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Treatment of cryptosporidiosis with spiramycin in AIDS. An "N of 1" trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

1 reference

7 January 2021

Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004932.PUB2

7 January 2021

10.1002/14651858.CD004932.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17253532

1 reference

Consolidated OpenCitations Corpus – April 2017